EVGNEvogene Ltd
$0.41
$0.0041
(0.99%)
Pre-Market
EarningsAug 20
Mkt Cap$5.14M
Vol17.66M
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery...
PR Newswire
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery...
PR Newswire
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and...
PR Newswire
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and...
PR Newswire
Full Transcript: Evogene Q1 2026 Earnings Call
read more...
Benzinga
Full Transcript: Evogene Q1 2026 Earnings Call
read more...
Benzinga
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
Evogene to Present Its Pharma Division Achievements at the BIO International Convention Evogene to Present Its Pharma Division Achievements at the BIO International Convention PR Newswire REHOVOT, Israel, June 9, 2026 Conference to be held in San Diego, CA, USA June 22-25, 2026REHOVOT, Israel, June...
PR Newswire
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
Evogene to Present Its Pharma Division Achievements at the BIO International Convention Evogene to Present Its Pharma Division Achievements at the BIO International Convention PR Newswire REHOVOT, Israel, June 9, 2026 Conference to be held in San Diego, CA, USA June 22-25, 2026REHOVOT, Israel, June...
PR Newswire
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial...
PR Newswire
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial...
PR Newswire
<
1
2
...
>
Advertisement|Remove ads.
Latest EVGN News
ViewEvogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
PR Newswire
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
PR Newswire
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization
PR Newswire
Advertisement|Remove ads.